SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling […]
Advancing Strategic Focus and Strengthening Financial Position Mooresville, NC, April 22, 2024 (GLOBE NEWSWIRE) — Fundamental Global Inc. (Nasdaq: FGF, […]